Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nandrolone for facilitating weaning from prolonged mechanical ventilation
IRCT20180804040695N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of nandrolone in respiratory failure, ventilator dependence (PMV) and respiratory muscle dysfunction (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoints: Age, Sex and 7 more. Started Oct 2018; status: completed.
02
Drugs
nandrolone
03
Conditions
respiratory failureventilator dependence (PMV)respiratory muscle dysfunction
Beyond the preview
Go deeper on IRCT20180804040695N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180804040695N1.